Effects of Vitamin B1 in Type 1 Diabetic Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

February 28, 2011

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Placebo

Placebo for benfotiamine

DRUG

Benfotiamine

300mg/day

Trial Locations (1)

0514

Aker University Hospital, Oslo

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

lead

University Hospital, Aker

OTHER

NCT00117026 - Effects of Vitamin B1 in Type 1 Diabetic Patients | Biotech Hunter | Biotech Hunter